CC Chemours Co

Overview and Growth

In fiscal 2025, Chemours Co recorded $5.81B of revenue, net loss of $386.00M, and an operating cash inflow of $264.00M. Revenue of $5.81B sets the scale for evaluating how effectively sales translated into profit and cash during the year. Revenue was 0.4% above fiscal 2024 revenue of $5.78B, marking a year-over-year increase. Diluted earnings per share were -$2.57, translating the period’s attributable earnings into the amount reported for each diluted share. The per-share result recorded a 658.7% decrease from fiscal 2024 diluted EPS of $0.46. Total assets stood at $7.38B, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Revenue equaled 0.79x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $902.00M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross margin was 15.5%, so that share of each revenue unit remained after the cost of revenue reported for the period. The company ended the period with a net loss of $386.00M, extending the operating result through all remaining items. Net margin was -6.6%, reflecting a loss equal to 6.6% of reported revenue. Before income taxes, the company recorded a loss of $277.00M, bridging the operating result to the final net loss. Pretax margin was -4.8%, reflecting a pre-tax loss equal to 4.8% of revenue. The company recognized $109.00M of income tax for the period, completing the transition from pretax income to net income. Relative to period-end equity, the net loss represented 153.8%. The net loss equaled 5.2% of period-end assets, showing the deficit relative to the asset base.

Liquidity and Capital Structure

At period end, the $7.38B asset base was financed through $7.13B of liabilities and $251.00M of equity. At period end, current assets of $3.00B compared with current liabilities of $1.69B, defining the company’s short-term resource position. At 1.78x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. The company held $670.00M in cash and equivalents, a narrower liquidity measure than total current assets. The cash balance equaled 39.7% of current liabilities, showing how much near-term coverage came from cash alone. Total debt was $4.14B, establishing the amount of borrowing carried within the company’s capital structure. Against book equity, debt measured 16.5x, placing the company’s financial leverage in clear balance-sheet terms. The debt-to-assets relationship was 56.1%, comparing borrowing with the total asset balance. The liabilities-to-assets relationship was 96.6%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 9.1%, comparing reported cash and equivalents with the full positive asset balance. The asset base changed 1.7% from $7.51B in fiscal 2024, leaving current total assets lower year over year. Book equity was 56.1% lower than fiscal 2024 equity of $572.00M, showing how shareholder capital changed year over year.

Cash Flow and Earnings Quality

The company reported $264.00M of operating cash flow, a cash inflow that shows the cash generated by operations. Capital expenditures used $213.00M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Capital expenditures represented 80.7% of operating cash flow, leaving the remainder available as free cash flow. After capital spending, free cash flow was $51.00M, leaving cash available for debt reduction, shareholder returns, or further investment. The free-cash-flow margin was 0.9%, measuring cash remaining after capital spending against revenue. Free cash flow equaled 0.7% of total assets, relating post-investment cash generation to the company’s resource base.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.